| scholarly article | Q13442814 |
| P50 | author | Jae Kim | Q43130925 |
| P2093 | author name string | Ellen M Unterwald | |
| Scott M Rawls | |||
| Bruce A Rasmussen | |||
| P2860 | cites work | Synaptic plasticity and addiction | Q22337221 |
| Activation of G-proteins in brain by endogenous and exogenous cannabinoids | Q24647703 | ||
| The endocannabinoid anandamide is a direct and selective blocker of the background K(+) channel TASK-1. | Q28354250 | ||
| Direct inhibition of T-type calcium channels by the endogenous cannabinoid anandamide | Q28366316 | ||
| Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide | Q28370516 | ||
| Methanandamide attenuates cocaine-induced hyperthermia in rats by a cannabinoid CB1-dopamine D2 receptor mechanism | Q28566274 | ||
| The neural basis of drug craving: an incentive-sensitization theory of addiction | Q29547475 | ||
| Isolation and structure of a brain constituent that binds to the cannabinoid receptor | Q29547476 | ||
| Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies | Q34022916 | ||
| Anandamide: some like it hot. | Q34296080 | ||
| Pharmacology of cannabinoid CB1 and CB2 receptors. | Q34442847 | ||
| Delta9-tetrahydrocannabinol and endogenous cannabinoid anandamide directly potentiate the function of glycine receptors | Q34473596 | ||
| Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. | Q34602111 | ||
| Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human | Q35120095 | ||
| Sensitization of midbrain dopamine neuron reactivity and the self-administration of psychomotor stimulant drugs | Q35690551 | ||
| Amphetamine-induced time-dependent sensitization of dopamine neurotransmission in the dorsal and ventral striatum: a microdialysis study in behaving rats | Q35768209 | ||
| Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats | Q35781905 | ||
| The role of endocannabinoid transmission in cocaine addiction | Q36144654 | ||
| Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction | Q36482564 | ||
| Cocaine reward and hyperactivity in the rat: sites of mu opioid receptor modulation | Q36978319 | ||
| Cocaine abuse and sensitization of striatal dopamine transmission: a critical review of the preclinical and clinical imaging literature | Q37249582 | ||
| The pharmacological and anatomical substrates of the amphetamine response in the rat | Q40305293 | ||
| Cannabinoid receptors: G-protein-mediated signal transduction mechanisms | Q40757082 | ||
| Amphetamine: effects on catecholamine systems and behavior | Q40908229 | ||
| Comparative effects of tetrahydrocannabinol on psychostimulant-induced behaviors | Q41536978 | ||
| Long-lasting nicotinic modulation of GABAergic synaptic transmission in the rat nucleus accumbens associated with behavioural sensitization to amphetamine | Q42461716 | ||
| The cannabinoid receptor antagonist SR-141716 does not readily antagonize open-field effects induced by the cannabinoid receptor agonist (R)-methanandamide in rats | Q42607871 | ||
| Anandamide and methanandamide induce both vanilloid VR1- and cannabinoid CB1 receptor-mediated changes in heart rate and blood pressure in anaesthetized rats. | Q43841348 | ||
| Psychostimulant-induced behavioral sensitization depends on nicotinic receptor activation. | Q43954521 | ||
| Behavioral sensitization to amphetamine follows chronic administration of the CB1 agonist WIN 55,212-2 in Lewis rats | Q44126671 | ||
| Arachidonic acid and anandamide have opposite modulatory actions at the glycine transporter, GLYT1a. | Q44297168 | ||
| The endogenous cannabinoid anandamide inhibits alpha7 nicotinic acetylcholine receptor-mediated responses in Xenopus oocytes | Q44453346 | ||
| Neuromorphological background of cannabis addiction | Q44494962 | ||
| Sodium channel inhibition by anandamide and synthetic cannabimimetics in brain. | Q44497328 | ||
| Differential effects of endogenous and synthetic cannabinoids on alpha7-nicotinic acetylcholine receptor-mediated responses in Xenopus Oocytes | Q44854907 | ||
| Endogenous cannabinoids are not involved in cocaine reinforcement and development of cocaine-induced behavioural sensitization | Q45168618 | ||
| Methanandamide allosterically inhibits in vivo the function of peripheral nicotinic acetylcholine receptors containing the alpha 7-subunit. | Q46528843 | ||
| WIN 55,212-2-induced reduction of cocaine hyperlocomotion: possible inhibition of 5-HT(3) receptor function | Q46550938 | ||
| Glycine receptors in CNS neurons as a target for nonretrograde action of cannabinoids. | Q46656522 | ||
| The CB(1) cannabinoid receptor antagonist AM251 attenuates amphetamine-induced behavioural sensitization while causing monoamine changes in nucleus accumbens and hippocampus | Q46737888 | ||
| The role of the CB1 cannabinoid receptor and its endogenous ligands, anandamide and 2-arachidonoylglycerol, in amphetamine-induced behavioural sensitization | Q46910414 | ||
| Methanandamide activation of a novel current in mouse trigeminal ganglion sensory neurons in vitro | Q48104343 | ||
| Role of cannabinoid type 1 receptors in locomotor activity and striatal signaling in response to psychostimulants | Q48124141 | ||
| Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent | Q48332786 | ||
| Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum | Q48440490 | ||
| Involvement of cannabinoid CB1 receptors in drug addiction: effects of rimonabant on behavioral responses induced by cocaine. | Q48630219 | ||
| Influence of the cannabinoid agonist HU 210 on cocaine- and CQP 201-403-induced behavioural effects in rat. | Q51443626 | ||
| Effects of pre-exposure and co-administration of the cannabinoid receptor agonist CP 55,940 on behavioral sensitization to cocaine. | Q51502955 | ||
| Modulation of the induction or expression of psychostimulant sensitization by the circumstances surrounding drug administration. | Q52188096 | ||
| Lack of effect of a glycine(B) receptor partial agonist on amphetamine-induced sensitization in mice. | Q53851310 | ||
| Endocannabinoids | Q55282369 | ||
| A role for vanilloid receptor 1 (TRPV1) and endocannabinnoid signalling in the regulation of spontaneous and L-DOPA induced locomotion in normal and reserpine-treated rats | Q60690596 | ||
| Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity | Q64386018 | ||
| Long-lasting effects of escalating doses of d-amphetamine on brain monoamines, amphetamine-induced stereotyped behavior and spontaneous nocturnal locomotion | Q68997706 | ||
| Extrapyramidal effects of methanandamide, an analog of anandamide, the endogenous CB1 receptor ligand | Q71040771 | ||
| The endogenous cannabinoid receptor ligand, anandamide, inhibits the motor behavior: role of nigrostriatal dopaminergic neurons | Q72302141 | ||
| A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants | Q73950418 | ||
| P433 | issue | 1-3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 150-155 | |
| P577 | publication date | 2009-10-30 | |
| P1433 | published in | European Journal of Pharmacology | Q1376712 |
| P1476 | title | Methanandamide blocks amphetamine-induced behavioral sensitization in rats | |
| P478 | volume | 627 |
| Q33985621 | Age-related differences in amphetamine sensitization: effects of prior drug or stress history on stimulant sensitization in juvenile and adult rats |
| Q42605212 | Dual role of PPAR-γ in induction and expression of behavioral sensitization to cannabinoid receptor agonist WIN55,212-2. |
Search more.